Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
gptkb:914257-21-9
|
| gptkbp:developedBy |
gptkb:Pfizer
|
| gptkbp:function |
fatty acid amide hydrolase inhibitor
|
| gptkbp:hasMolecularFormula |
C23H20F3N3O2
|
| https://www.w3.org/2000/01/rdf-schema#label |
914257-21-9
|
| gptkbp:molecularWeight |
427.42 g/mol
|
| gptkbp:name |
gptkb:PF-04457845
|
| gptkbp:PubChem_CID |
25154816
|
| gptkbp:synonym |
gptkb:PF-04457845
N-[(1S)-1-(Cyclohexylamino)-3-(3-trifluoromethylphenyl)propyl]-4-pyridinecarboxamide |
| gptkbp:bfsParent |
gptkb:obiltoxaximab
|
| gptkbp:bfsLayer |
8
|